Ultra-Low-Dose Radiation Relieved Multiple Myeloma Pain
Patients with painful bone lesions experienced improved relief using lower radiation doses in a new clinical study.
Updated on Sept. 27, 2026 in Cancer
Live Poll
Should doctors offer pain-relieving therapies earlier in the treatment of chronic bone disease?
A phase II clinical trial has found that ultra-low-dose radiation therapy effectively manages bone pain for patients with multiple myeloma. These findings suggest that patients could experience significant relief with less radiation than is typically administered.
Why it matters
Radiation therapy serves as a critical early intervention to prevent patients from experiencing prolonged pain while awaiting systemic therapy. Adopting this lower-dose approach may allow clinicians to manage pain symptoms more effectively early in the course of bone disease.
In a phase II trial of 63 patients with multiple myeloma, researchers evaluated the efficacy of 4 Gy of external beam radiation. Results showed an 82% pain response rate at six months, with a median time to pain relief of 36 days.
The players
ASTRO
The American Society for Radiation Oncology is the professional organization that hosts the annual meeting where this research was presented.
The details
The treatment involved administering 4 Gy of external beam radiation to patients, delivered as either a single fraction or two fractions. This approach works by targeting painful, uncomplicated myeloma bone lesions to reduce local discomfort. For the 24% of participants who required additional management, a second course of radiation was provided at a median dose of 20 Gy.
Timeline
The phase II trial took place between April 2019 and September 2025.
Results were presented at the ASTRO annual meeting on September 27, 2026.
Health Landscape
This study shifts the clinical focus toward earlier, less intensive radiotherapy as a standard for myeloma bone pain. It builds on the ongoing research presented at the ASTRO annual meeting to refine how radiation is deployed alongside systemic therapies.
If you are managing bone pain associated with multiple myeloma, it is worth discussing with your doctor whether early, lower-dose radiation therapy is appropriate for your specific lesions. Keep in mind that individual response times vary, as the median time to relief in this study was 36 days.
The takeaway
Using targeted low-dose radiation can provide sustained pain relief for myeloma patients while potentially sparing them higher cumulative doses. Patients should work closely with their oncology team to monitor pain levels and determine if radiation intervention is the right step for their care plan.
Further reading
For more on evolving approaches to managing bone disease, visit our Cancer section.
Live Poll
Should doctors offer pain-relieving therapies earlier in the treatment of chronic bone disease?
